Life ScienceCompany
GlaxoSmithKline - Opiates Business Ownership
Who owns GlaxoSmithKline - Opiates Business?
GlaxoSmithKline - Opiates Business is owned by Sun Pharmaceuticals Industries. It was acquired on March 3, 2015.
GlaxoSmithKline - Opiates Business Business Overview
Where is GlaxoSmithKline - Opiates Business headquartered?
GlaxoSmithKline - Opiates Business is headquartered in Australia.
What sector is GlaxoSmithKline - Opiates Business in?
GlaxoSmithKline - Opiates Business is a life science company.
Life Science M&A Summary in 2015
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.
Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.